HUNYVERS SACA (ALHUN.PA) Fundamental Analysis & Valuation

EPA:ALHUN • FR0014007LQ2

Current stock price

7 EUR
0 (0%)
Last:

This ALHUN.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ALHUN.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALHUN has reported negative net income.
  • In the past year ALHUN had a positive cash flow from operations.
  • Of the past 5 years ALHUN 4 years were profitable.
  • ALHUN had a positive operating cash flow in 4 of the past 5 years.
ALHUN.PA Yearly Net Income VS EBIT VS OCF VS FCFALHUN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M -4M 6M

1.2 Ratios

  • ALHUN's Return On Assets of -0.85% is on the low side compared to the rest of the industry. ALHUN is outperformed by 61.40% of its industry peers.
  • ALHUN's Return On Equity of -2.71% is in line compared to the rest of the industry. ALHUN outperforms 40.35% of its industry peers.
  • The Return On Invested Capital of ALHUN (1.38%) is worse than 64.91% of its industry peers.
  • ALHUN had an Average Return On Invested Capital over the past 3 years of 5.10%. This is below the industry average of 9.66%.
Industry RankSector Rank
ROA -0.85%
ROE -2.71%
ROIC 1.38%
ROA(3y)1.9%
ROA(5y)3.61%
ROE(3y)6.17%
ROE(5y)19.19%
ROIC(3y)5.1%
ROIC(5y)7.41%
ALHUN.PA Yearly ROA, ROE, ROICALHUN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 20 40

1.3 Margins

  • Looking at the Operating Margin, with a value of 0.71%, ALHUN is doing worse than 64.91% of the companies in the same industry.
  • ALHUN's Operating Margin has improved in the last couple of years.
  • ALHUN has a Gross Margin of 21.04%. This is in the lower half of the industry: ALHUN underperforms 75.44% of its industry peers.
  • ALHUN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 0.71%
PM (TTM) N/A
GM 21.04%
OM growth 3Y-52.03%
OM growth 5Y16.26%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.64%
GM growth 5Y4.95%
ALHUN.PA Yearly Profit, Operating, Gross MarginsALHUN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20

3

2. ALHUN.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALHUN is destroying value.
  • Compared to 1 year ago, ALHUN has about the same amount of shares outstanding.
  • ALHUN has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ALHUN has an improved debt to assets ratio.
ALHUN.PA Yearly Shares OutstandingALHUN.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M
ALHUN.PA Yearly Total Debt VS Total AssetsALHUN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

  • ALHUN has an Altman-Z score of 2.22. This is not the best score and indicates that ALHUN is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.22, ALHUN is in line with its industry, outperforming 59.65% of the companies in the same industry.
  • The Debt to FCF ratio of ALHUN is 4.56, which is a neutral value as it means it would take ALHUN, 4.56 years of fcf income to pay off all of its debts.
  • ALHUN has a Debt to FCF ratio (4.56) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.62 indicates that ALHUN is somewhat dependend on debt financing.
  • ALHUN has a Debt to Equity ratio of 0.62. This is comparable to the rest of the industry: ALHUN outperforms 52.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 4.56
Altman-Z 2.22
ROIC/WACC0.21
WACC6.63%
ALHUN.PA Yearly LT Debt VS Equity VS FCFALHUN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 10M 20M

2.3 Liquidity

  • ALHUN has a Current Ratio of 1.58. This is a normal value and indicates that ALHUN is financially healthy and should not expect problems in meeting its short term obligations.
  • ALHUN has a better Current ratio (1.58) than 73.68% of its industry peers.
  • A Quick Ratio of 0.48 indicates that ALHUN may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.48, ALHUN is doing worse than 63.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 0.48
ALHUN.PA Yearly Current Assets VS Current LiabilitesALHUN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

5

3. ALHUN.PA Growth Analysis

3.1 Past

  • ALHUN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -139.58%.
  • ALHUN shows a decrease in Revenue. In the last year, the revenue decreased by -5.84%.
  • The Revenue has been growing by 25.60% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-139.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40.22%
Revenue 1Y (TTM)-5.84%
Revenue growth 3Y8.17%
Revenue growth 5Y25.6%
Sales Q2Q%-6.27%

3.2 Future

  • Based on estimates for the next years, ALHUN will show a very strong growth in Earnings Per Share. The EPS will grow by 139.47% on average per year.
  • Based on estimates for the next years, ALHUN will show a quite strong growth in Revenue. The Revenue will grow by 8.52% on average per year.
EPS Next Y653.33%
EPS Next 2Y229.65%
EPS Next 3Y139.47%
EPS Next 5YN/A
Revenue Next Year11.51%
Revenue Next 2Y9.35%
Revenue Next 3Y8.52%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALHUN.PA Yearly Revenue VS EstimatesALHUN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M
ALHUN.PA Yearly EPS VS EstimatesALHUN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

5

4. ALHUN.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALHUN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 6.01 indicates a rather cheap valuation of ALHUN.
  • Based on the Price/Forward Earnings ratio, ALHUN is valued cheaper than 89.47% of the companies in the same industry.
  • ALHUN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.42.
Industry RankSector Rank
PE N/A
Fwd PE 6.01
ALHUN.PA Price Earnings VS Forward Price EarningsALHUN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

  • 70.18% of the companies in the same industry are cheaper than ALHUN, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, ALHUN is valued a bit cheaper than the industry average as 71.93% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.49
EV/EBITDA 22.62
ALHUN.PA Per share dataALHUN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • ALHUN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ALHUN's earnings are expected to grow with 139.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y229.65%
EPS Next 3Y139.47%

0

5. ALHUN.PA Dividend Analysis

5.1 Amount

  • ALHUN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ALHUN.PA Fundamentals: All Metrics, Ratios and Statistics

HUNYVERS SACA

EPA:ALHUN (3/20/2026, 7:00:00 PM)

7

0 (0%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners6.48%
Inst Owner ChangeN/A
Ins Owners2.63%
Ins Owner ChangeN/A
Market Cap27.09M
Revenue(TTM)122.72M
Net Income(TTM)-751.60K
Analysts86.67
Price Target11.73 (67.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)66.18%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.01
P/S 0.22
P/FCF 5.49
P/OCF 5.07
P/B 0.98
P/tB 2.02
EV/EBITDA 22.62
EPS(TTM)-0.19
EYN/A
EPS(NY)1.16
Fwd EY16.63%
FCF(TTM)1.28
FCFY18.22%
OCF(TTM)1.38
OCFY19.71%
SpS31.71
BVpS7.17
TBVpS3.47
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.85%
ROE -2.71%
ROCE 1.95%
ROIC 1.38%
ROICexc 1.38%
ROICexgc 2%
OM 0.71%
PM (TTM) N/A
GM 21.04%
FCFM 4.02%
ROA(3y)1.9%
ROA(5y)3.61%
ROE(3y)6.17%
ROE(5y)19.19%
ROIC(3y)5.1%
ROIC(5y)7.41%
ROICexc(3y)6.57%
ROICexc(5y)10.28%
ROICexgc(3y)9.69%
ROICexgc(5y)14.87%
ROCE(3y)7.22%
ROCE(5y)11%
ROICexgc growth 3Y-47.55%
ROICexgc growth 5Y10.21%
ROICexc growth 3Y-49.99%
ROICexc growth 5Y5.05%
OM growth 3Y-52.03%
OM growth 5Y16.26%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.64%
GM growth 5Y4.95%
F-Score6
Asset Turnover1.39
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 4.56
Debt/EBITDA 8.1
Cap/Depr 32.36%
Cap/Sales 0.33%
Interest Coverage 250
Cash Conversion 252.1%
Profit Quality N/A
Current Ratio 1.58
Quick Ratio 0.48
Altman-Z 2.22
F-Score6
WACC6.63%
ROIC/WACC0.21
Cap/Depr(3y)101.83%
Cap/Depr(5y)104.22%
Cap/Sales(3y)0.69%
Cap/Sales(5y)0.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-139.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40.22%
EPS Next Y653.33%
EPS Next 2Y229.65%
EPS Next 3Y139.47%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.84%
Revenue growth 3Y8.17%
Revenue growth 5Y25.6%
Sales Q2Q%-6.27%
Revenue Next Year11.51%
Revenue Next 2Y9.35%
Revenue Next 3Y8.52%
Revenue Next 5YN/A
EBIT growth 1Y-73.1%
EBIT growth 3Y-48.11%
EBIT growth 5Y46.02%
EBIT Next Year92.75%
EBIT Next 3Y44.8%
EBIT Next 5YN/A
FCF growth 1Y195.45%
FCF growth 3Y102.19%
FCF growth 5Y67.52%
OCF growth 1Y222.08%
OCF growth 3Y63.97%
OCF growth 5Y58.02%

HUNYVERS SACA / ALHUN.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HUNYVERS SACA (ALHUN.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALHUN.PA.


Can you provide the valuation status for HUNYVERS SACA?

ChartMill assigns a valuation rating of 5 / 10 to HUNYVERS SACA (ALHUN.PA). This can be considered as Fairly Valued.


What is the profitability of ALHUN stock?

HUNYVERS SACA (ALHUN.PA) has a profitability rating of 2 / 10.


What is the financial health of HUNYVERS SACA (ALHUN.PA) stock?

The financial health rating of HUNYVERS SACA (ALHUN.PA) is 4 / 10.